Wei Xu

2.9k total citations · 1 hit paper
152 papers, 1.9k citations indexed

About

Wei Xu is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Wei Xu has authored 152 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Surgery, 38 papers in Molecular Biology and 35 papers in Oncology. Recurrent topics in Wei Xu's work include Cancer, Lipids, and Metabolism (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers) and Pancreatic and Hepatic Oncology Research (9 papers). Wei Xu is often cited by papers focused on Cancer, Lipids, and Metabolism (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers) and Pancreatic and Hepatic Oncology Research (9 papers). Wei Xu collaborates with scholars based in China, United States and Canada. Wei Xu's co-authors include Bisrat G. Debeb, Naoto T. Ueno, Wendy A. Woodward, Takeshi Suda, Guisheng Zhang, Dexi Liu, Kenya Kamimura, Lara Lacerda, Richard Larson and Jagadese J. Vittal and has published in prestigious journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Wei Xu

137 papers receiving 1.9k citations

Hit Papers

Association between the triglyceride–glucose index and se... 2022 2026 2023 2024 2022 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Xu China 24 740 380 286 257 249 152 1.9k
Gerasimos Tsourouflis Greece 22 861 1.2× 451 1.2× 332 1.2× 402 1.6× 205 0.8× 104 1.9k
Takako Asano Japan 27 1.3k 1.7× 378 1.0× 469 1.6× 219 0.9× 412 1.7× 84 2.1k
Chunli Shao China 16 619 0.8× 442 1.2× 205 0.7× 212 0.8× 140 0.6× 58 1.6k
Paul O’Connor United States 32 1.2k 1.6× 439 1.2× 240 0.8× 329 1.3× 354 1.4× 76 3.1k
C. Rancoule France 22 687 0.9× 312 0.8× 198 0.7× 231 0.9× 311 1.2× 77 1.7k
Xinchun Zhou United States 22 1.1k 1.6× 243 0.6× 517 1.8× 188 0.7× 216 0.9× 62 1.9k
Clara E. Magyar United States 29 1.5k 2.0× 380 1.0× 296 1.0× 247 1.0× 404 1.6× 66 2.5k
Antien L. Mooyaart Netherlands 17 450 0.6× 350 0.9× 161 0.6× 194 0.8× 255 1.0× 59 2.2k
Ying Shen China 30 1.0k 1.4× 295 0.8× 355 1.2× 353 1.4× 336 1.3× 129 2.4k
Peter Dietrich Germany 21 543 0.7× 172 0.5× 229 0.8× 197 0.8× 114 0.5× 50 1.3k

Countries citing papers authored by Wei Xu

Since Specialization
Citations

This map shows the geographic impact of Wei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Xu more than expected).

Fields of papers citing papers by Wei Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Xu. The network helps show where Wei Xu may publish in the future.

Co-authorship network of co-authors of Wei Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Xu. A scholar is included among the top collaborators of Wei Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Xu. Wei Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Wei, et al.. (2025). Association of atherogenic index of plasma with early-onset post-stroke depression: a prospective study. Frontiers in Psychiatry. 16. 1563289–1563289.
2.
Xu, Wei, Zheng Xu, Henry H. Y. Tong, et al.. (2025). Diagnosis of Irritant Dermatitis in Colorectal Cancer Postoperative Stoma Patients Using Smartphone Photographs: A Deep Learning Approach. Journal of Multidisciplinary Healthcare. Volume 18. 2215–2223.
3.
Liu, Xuan, Bowang Chen, Xueke Bai, et al.. (2025). Area-level socioeconomic inequalities in hypertension care cascade in China: a nationwide population-based study based on the ChinaHEART project. The Lancet Regional Health - Western Pacific. 57. 101544–101544.
5.
Xu, Wei, Baokun Zhang, Shanshan Lu, et al.. (2024). Clinical features and mechanisms of neck myoclonus in narcolepsy. Sleep Medicine. 123. 22–28.
6.
Wu, Shuang, Yanmin Yang, Jun Zhu, et al.. (2024). Association between adherence to life’s simple 7 metrics and risk of obstructive sleep apnea among adults in the United States. BMC Psychiatry. 24(1). 560–560. 1 indexed citations
7.
Zhu, Jun, Jiang‐Shan Tan, Lulu Wang, et al.. (2024). Rate control or rhythm control in patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention. Heliyon. 10(15). e35218–e35218. 2 indexed citations
8.
Zhou, Nina, Zhen Wang, Wei Zhao, et al.. (2024). Higher homocysteine and fibrinogen are associated with early-onset post-stroke depression in patients with acute ischemic stroke. Frontiers in Psychiatry. 15. 1371578–1371578. 5 indexed citations
10.
Xu, Wei, et al.. (2023). GADD45B regulates the carcinogenesis process of chronic atrophic gastritis and the metabolic pathways of gastric cancer. Frontiers in Endocrinology. 14. 1224832–1224832. 12 indexed citations
11.
Zhou, Xinyuan, Pan Zhang, Nan Liu, et al.. (2023). Enhancing chemotherapy for pancreatic cancer through efficient and sustained tumor microenvironment remodeling with a fibroblast-targeted nanosystem. Journal of Controlled Release. 361. 161–177. 17 indexed citations
12.
Liu, Yujiao, Yixuan Liu, Wei Xu, et al.. (2023). Studying allosteric regulation of chemokines and antagonists using a nanoscale hCCR3 receptor sensor. International Journal of Biological Macromolecules. 253(Pt 4). 126892–126892. 1 indexed citations
13.
Yu, Liang, Qiqin Wang, Wennian Yu, et al.. (2023). Ovulation induction drug and ovarian cancer: an updated systematic review and meta-analysis. Journal of Ovarian Research. 16(1). 22–22. 4 indexed citations
15.
Lu, Jiapeng, Guiyuan Han, Xiaoying Liu, et al.. (2023). Association of high-density lipoprotein cholesterol with all-cause and cause-specific mortality in a Chinese population of 3.3 million adults: a prospective cohort study. The Lancet Regional Health - Western Pacific. 42. 100874–100874. 30 indexed citations
16.
Xu, Wei, et al.. (2022). CHRDL2 promotes cell proliferation by activating the YAP/TAZ signaling pathway in gastric cancer. Free Radical Biology and Medicine. 193(Pt 1). 158–170. 6 indexed citations
18.
Chen, Zan & Wei Xu. (2019). Targeting E3 ubiquitin ligases to sensitize cancer radiation therapy. SHILAP Revista de lepidopterología. 3(3). 105–110. 1 indexed citations
19.
Zhou, Zhi, et al.. (2018). Da Vinci robot assistance surgical coordination for the resection of azygous vein aneurysm: a case report. ˜The œJournal of practical nursing. 34(32). 2517–2519. 1 indexed citations
20.
Zhu, Kai, Jiaoxing Li, Xin Huang, et al.. (2017). Thymectomy is a beneficial therapy for patients with non-thymomatous ocular myasthenia gravis: a systematic review and meta-analysis. Neurological Sciences. 38(10). 1753–1760. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026